|
06 Nov 2020 |
OSE Immunotherapeutics Provides COVID-19 Vaccine Update on CoVepiT, its Multi-Target and Long-Lasting Vaccine Candidate
|
|
02 Nov 2020 |
CureVac Reports Positive Interim Phase 1 Data for its COVID-19 Vaccine Candidate, CVnCoV
|
|
02 Nov 2020 |
First Healthy Volunteer Dosed in Symvivo’s Phase 1 Clinical Trial of bacTRL-Spike™, an Oral COVID-19 Vaccine Candidate
|
|
31 Oct 2020 |
Icosavax Launches COVID-19 Vaccine Program with Preclinical Data and $16.5 Million in New Funding
|
|
30 Oct 2020 |
OncoSec Announces FDA Clearance of IND Application for Initiation of Phase 1 Clinical Trial of its CORVax12 Vaccine Candidate for COVID-19
|
|
29 Oct 2020 |
HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-202/HB-201 Alternating Vector Therapy to Treat Human Papillomavirus 16-Positive Cancers
|
|
27 Oct 2020 |
Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update
|
|
27 Oct 2020 |
Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 2 Dose-Expansion Portion of Study Evaluating Investigational WT1 Immunotherapeutic Cancer Vaccine DSP-7888 (ombipepimut-S*) in Patients with Ovarian Cancer
|
|
27 Oct 2020 |
Department of Defense Awards Ology Bioservices Contract to Manufacture and Test Novel Live Attenuated Tularemia Vaccine Candidate
|
|
27 Oct 2020 |
TFF Pharmaceuticals Announces Positive Preclinical Results with University of Georgia Universal Influenza Vaccines
|
|
26 Oct 2020 |
PDS Biotech Announces Initiation of Phase 2 Trial of PDS0101 in Combination with Standard of Care Chemoradiotherapy in Advanced Cervical Cancer
|
|
26 Oct 2020 |
Advaxis’ ADXS-503 (HOT Lung) Demonstrates Pronounced and Sustained Tumor Control in Ongoing Phase 1/2 Lung Cancer Trial
|
|
26 Oct 2020 |
Allergy Therapeutics announces start of innovative exploratory field study to evaluate efficacy and safety of Grass MATA MPL
|
|
25 Oct 2020 |
BiondVax Announces Topline Results from Phase 3 Clinical Trial of the M-001 Universal Influenza Vaccine Candidate
|
|
25 Oct 2020 |
FDA authorises restart of the COVID-19 AZD1222 vaccine US Phase III trial
|
|
23 Oct 2020 |
Moderna Completes Enrollment of Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273)
|
|
22 Oct 2020 |
ImmunityBio, NantKwest Announce First Patient Dosed in Phase 1 Clinical Trial of Novel COVID-19 Vaccine Candidate hAd5
|
|
22 Oct 2020 |
GSK presents positive clinical data on maternal and older adults RSV candidate vaccines
|
|
21 Oct 2020 |
Valneva Announces Positive Initial Results for Second Phase 2 Study of Lyme Disease Vaccine Candidate VLA15
|
|
21 Oct 2020 |
Merck Announces Positive Topline Results from Two Additional Phase 3 Adult Studies Evaluating V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine
|
|
21 Oct 2020 |
Affinivax Announces the Presentation of Phase 1 Clinical Data for its MAPS™ Vaccine for Streptococcus pneumoniae at IDWeek 2020
|
|
19 Oct 2020 |
Ultimovacs Announces Updated Positive Results from Phase I Trial Evaluating Universal Cancer Vaccine, UV1, in Non-Small Cell Lung Cancer
|
|
16 Oct 2020 |
FDA Authorizes Phase 1 Trial of ImmunityBio’s Novel COVID-19 Vaccine Candidate hAd5; Dual Construct is Designed to Drive Both T Cell and Antibody Immunity
|
|
15 Oct 2020 |
Sanofi and Translate Bio mRNA COVID-19 Vaccine Candidate Induced High Antibody Levels in Preclinical Studies
|
|
14 Oct 2020 |
Vaxart Announces Positive Hamster Challenge Study Data for its Oral COVID-19 Vaccine
|
